RT 10MG

RT – Triple Agonist peptide: a novel triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. This investigational research compound is available from Maple Research Labs at 10mg per vial with greater than 99%+ HPLC-verified purity and batch-specific COA.

Product Specifications

• Alternative Names: LY-3437943, GGG Tri-Agonist
• Receptor Targets: GLP-1R, GIPR, GCGR
• Purity: >99%+ (HPLC verified)
• Form: Lyophilized powder
• Quantity: 10mg per vial

RT – Triple Agonist Peptide Research Summary

RT (LY-3437943) is a synthetic peptide developed as a triple agonist of the GLP-1 receptor (GLP-1R), GIP receptor (GIPR), and glucagon receptor (GCGR). This triple agonist approach distinguishes it from dual agonists such as tirzepatide and single agonists such as semaglutide in preclinical metabolic research.

Mechanism of Action Research

RT engages three distinct G protein-coupled receptors with complementary downstream signaling effects studied in preclinical models. Published binding affinity studies have characterized the peptide relative activity at each receptor, with the highest potency reported at the GIPR, followed by GLP-1R and GCGR.

All findings referenced are from preclinical research and early-phase investigations. Researchers should consult primary literature for complete experimental protocols.

Certificate of Analysis (COA)

Testing Laboratory: Testides Analytical. Purity (HPLC-UV): 99.71%. Report: DBAV-RETA-10-062726. Download Full COA (PDF)

For research purposes only. Not for human consumption. Not for diagnostic or therapeutic use.

About this RT reference material

RT Triple Agonist is supplied by Maple Research Labs as a lyophilised powder in a sealed vial under catalogue reference RETA-10MG. Every vial is drawn from a single production batch and is released only against a batch-specific certificate of analysis. The batch documented for this listing was tested by Testides Analytical, an independent third-party laboratory, and the report reference is shown in the specification above.

Analytical specification for this RT batch

Identity and purity were determined by high-performance liquid chromatography with ultraviolet detection (HPLC-UV) and reported at 99.71%. The material is registered under CAS 2381089-83-2, molecular formula C205H320N56O63S2. HPLC-UV separates the target compound from related substances and process impurities and quantifies each as a percentage of total peak area, which is why the result is stated to two decimal places rather than as a rounded claim. Public registry data for CAS 2381089-83-2 can be checked independently via PubChem.

What a batch-specific COA means

A batch-specific certificate describes the exact material in the vial being shipped, not a representative sample from an earlier production run. Where a supplier publishes a single document covering an entire product line, that certificate cannot describe the unit received. Maple Research Labs does not publish a RT listing without a matching batch document, and the certificate for this batch is downloadable from this page.

Handling and storage

Supplied as a lyophilised powder. Store sealed vials away from light and moisture; refrigeration extends the shelf stability of the dry powder. Allow a chilled vial to reach ambient temperature before opening, to limit condensation on the stopper. Handle in a controlled laboratory environment using appropriate personal protective equipment, and record the batch reference against your own experimental documentation.

Availability and shipping

Orders ship from the United States. RT is listed as a single vial, so a laboratory can verify the certificate and the material against its own analytical methods before committing to a larger order.

For research purposes only. Not for human consumption. Not for diagnostic or therapeutic use.

Third-party testing and traceability for Retatrutide

Testing for RT is commissioned from Testides Analytical, a laboratory independent of both Maple Research Labs and the manufacturer. Independent testing matters because an in-house result is produced by the party with an interest in the outcome, and a third-party result is not. Each certificate states the analytical method used, the date of analysis and the batch identifier, so a result can be traced to a specific production run rather than to a product name in general.

Laboratories sourcing RT for method development or comparative work generally need three things on file: a purity figure produced by a stated method, a batch identifier that matches the vial in hand, and a supplier willing to publish both before purchase rather than after. Those are the terms this listing is published on, and the certificate is available without an account or an enquiry.